PP 2.14 – 00162 Elucidating the effects of combination therapy with Venetoclax and IAP inhibitor AZD5582 in SIV-infected, ART-suppressed macaques

Affiliations

B. Ukhueduan: Department of Pediatrics, Emory University, Atlanta, Georgia, USA
L. Lopez Lopez: Department of Pediatrics, Emory University, Atlanta, Georgia, USA
K. Bricker: Department of Pediatrics, Emory University, Atlanta, Georgia, USA
N. Schoof: Department of Pediatrics, Emory University, Atlanta, Georgia, USA
S. Vidisha: Department of Pediatrics, Emory University, Atlanta, Georgia, USA
D. Amir: Department of Pediatrics, Emory University, Atlanta, Georgia, USA
M. Mavigner: Department of Pediatrics, Emory University, Atlanta, Georgia, USA
A. Schauer: Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA
M.L. Cottrell: Center for Childhood Infection and Vaccine of Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
A. Chahroudi: Center for Childhood Infection and Vaccine of Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA

Abstract

No abstracts available.